기관지 확장제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 459억 7,000만 달러로 예측되며, 연평균 성장율(CAGR) 6.6%로 성장할 전망입니다. 예측 기간의 성장은 COPD 유병률 증가, 연구 개발 노력의 증가로 인한 폐 질환 치료에 대한 인식 상승, 폐 질환 유병률 증가, 가처분 소득 증가 및 흡연율 증가에 기인 할 수 있습니다. 예측 기간의 주요 동향으로는 고급 임상 연구 및 혁신 전략, 기술 발전, COPD 및 천식과 같은 폐 질환의 높은 유병률, 신제품 출시, 급성 호흡기 감염 환자 수 증가 등이 있습니다.
만성폐쇄성폐질환(COPD)의 유병률 증가는 가까운 미래에 기관지 확장제 시장의 성장을 견인할 것으로 보입니다.기도의 만성 염증과 기류의 폐쇄 또는 제한을 특징으로 하는 COPD는 전 세계적으로 심각한 건강 문제를 야기하고 있습니다. 기관지 확장제는 기도 주변 근육을 이완시켜 기도의 개방을 촉진하고 호흡 곤란을 완화함으로써 COPD 관리에 중요한 역할을 합니다. 예를 들어, 2023년 3월 스코틀랜드 공중보건국이 주도한 스코틀랜드 공중보건관측소의 보고서에 따르면 코로나19의 영향이 진정되기 시작하면서 COPD 발병률이 눈에 띄게 증가한 것으로 나타났습니다. 인구 10만 명당 COPD 발병률은 남성의 경우 83.2명에서 97.6명으로, 여성의 경우 72.6명에서 97.3명으로 급증했습니다. 결과적으로 COPD의 유병률 증가는 기관지 확장제 시장의 성장을 촉진하는 주요 동인으로 작용합니다.
기관지 확장제 시장의 저명한 업체들은 진화하는 환자의 요구를 충족하고 치료 결과를 개선하기 위해 전략적으로 혁신적인 제품 개발에 집중하고 있습니다. 2023년 1월 인도의 선도적인 제약 회사인 루핀은 천식 관리를 위해 인다카테롤, 글리코피로니움, 모메타손으로 구성된 고정 용량 3제 기관지 확장제인 디피즈마(DIFIZMA)를 출시했습니다. 건조 분말 흡입제인 디피즈마는 인도 의약품관리국(DCGI)이 불충분하게 조절되지 않는 천식 치료에 대해 승인한 유일한 고정 용량 복합제로서 주목받고 있습니다. 이 혁신적인 제형은 천식 환자의 폐 기능 개선, 증상 조절 강화, 악화 감소에 효능이 있음을 입증했습니다. 루팡과 같은 기업은 이러한 첨단 솔루션을 제공함으로써 미충족 의료 수요를 해결하고 기관지 확장제 시장의 지속적인 성장과 발전에 기여하는 것을 목표로 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 기관지 확장제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 기관지 확장제 시장 : 성장률 분석
- 세계의 기관지 확장제 시장 실적 : 규모와 성장(2019-2024년)
- 세계의 기관지 확장제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
- 세계의 기관지 확장제 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 기관지 확장제 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 베타 아드레날린 기관지 확장제
- 항콜린성 기관지 확장제
- 크산틴 유도체
- 기타 유형
- 세계의 기관지 확장제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 경구
- 비강(흡입)
- 주사제
- 세계의 기관지 확장제 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 천식
- 만성 폐색성 폐질환(COPD)
- 알레르기 반응
- 호흡 장애
- 기타
- 세계의 기관지 확장제 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 병원
- 전문 클리닉
- 기타 최종 사용자
- 세계의 기관지 확장제 시장 : 베타 아드레날린 기관지 확장제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 단시간 작용형 베타 자극제(SABA)
- 장시간 작용형 베타 자극제(LABA)
- 세계의 기관지 확장제 시장 : 항콜린성 기관지 확장제 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 단시간 작용형 항콜린제
- 장시간 작용형 항콜린제
- 세계의 기관지 확장제 시장: 크산틴 유도체 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 테오필린
- 아미노필린
- 세계의 기관지 확장제 시장: 기타 유형별, 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 류코트리엔 수용체 길항제
- 병용 요법
제7장 지역별 및 국가별 분석
- 세계의 기관지 확장제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 기관지 확장제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 기관지 확장제 시장 : 경쟁 구도
- 기관지 확장제 시장 : 기업 프로파일
- Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Johnson & Johnson Services Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- F. Hoffmann-La Roche Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
- Bayer AG 개요, 제품 및 서비스, 전략 및 재무 분석
- Novartis AG 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Thermo Fisher Scientific
- Abbott Laboratories
- Sanofi SA
- GlaxoSmithKline plc
- Siemens Healthcare GmbH
- Merck & Co. Inc.
- AstraZeneca plc
- Teva Pharmaceuticals Industries Ltd.
- Mylan NV
- Quest Diagnostics Incorporated.
- Boehringer Ingelheim International GmbH
- Aurobindo Pharma Limited
- Bio-Rad Laboratories Inc.
- Cipla Limited
- Hikma Pharmaceutical plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 기관지 확장제 시장(2029년) : 새로운 기회를 제공하는 국가
- 기관지 확장제 시장(2029년) : 새로운 기회를 제공하는 부문
- 기관지 확장제 시장(2029년) : 성장 전략
제36장 부록
HBR
Bronchodilators are medications designed to make breathing easier by relaxing the muscles in the lungs and widening the airways (bronchi). They are commonly employed in the treatment of long-term conditions characterized by narrow and inflamed airways, such as asthma and chronic obstructive pulmonary disease (COPD).
The main types of bronchodilators include beta-adrenergic bronchodilators, anticholinergic bronchodilators, xanthine derivatives, and others. Beta-adrenergic bronchodilators, a specific class of medications, function by binding to beta-adrenergic receptors in the smooth muscles of the airways. This binding induces relaxation and dilation of the airways, improving airflow and alleviating symptoms such as wheezing, coughing, and shortness of breath. These bronchodilators can be administered through various routes such as oral, nasal (inhalation), and injectable. They are used for treating conditions such as asthma, COPD, allergic reactions, breathing problems, and other indications. The end users of bronchodilators include hospitals, specialty clinics, and various healthcare facilities.
The bronchodilators market research report is one of a series of new reports from The Business Research Company that provides bronchodilators market statistics, including bronchodilators industry global market size, regional shares, competitors with a bronchodilators market share, detailed bronchodilators market segments, market trends and opportunities, and any further data you may need to thrive in the bronchodilators industry. This bronchodilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bronchodilators market size has grown strongly in recent years. It will grow from $32.93 billion in 2024 to $35.66 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to growing geriatric population, rising incidence of asthma, growing funding by government organizations, increase in ageing population, and increasing air pollution across the globe.
The bronchodilators market size is expected to see strong growth in the next few years. It will grow to $45.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of COPD, rising awareness about lung diseases treatment aided with escalating research and development efforts, increase in prevalence of pulmonary disorders, the rise in disposable income, and increasing smoking rates. Major trends in the forecast period include advanced clinical research and innovative strategies, growing technological advancements, high prevalence of lung diseases such as COPD and asthma, new product launches, and rising number of patients with acute respiratory infections.
The escalating prevalence of chronic obstructive pulmonary disease (COPD) is poised to drive the growth of the bronchodilator market in the foreseeable future. COPD, characterized by chronic inflammation of the airways and obstruction or limitation of airflow, represents a significant health challenge globally. Bronchodilators play a crucial role in COPD management by relaxing the muscles around the airways, thereby facilitating the opening of air passages and easing breathing difficulties. For instance, data from a report by the Scottish Public Health Observatory in March 2023, led by Public Health Scotland, revealed a notable increase in COPD rates as the impact of COVID-19 began to subside. The rate of COPD cases per 100,000 individuals surged from 83.2 to 97.6 among males and from 72.6 to 97.3 among females. Consequently, the rising prevalence of COPD serves as a primary driver propelling the growth of the bronchodilator market.
Prominent players in the bronchodilator market are strategically focused on the development of innovative products to cater to evolving patient needs and enhance treatment outcomes. One notable innovation gaining traction is fixed-dose triple-drug combinations-a medication formulation containing three active ingredients in predetermined doses within a single formulation. For example, in January 2023, Lupin, a leading pharmaceutical firm based in India, introduced DIFIZMA, a fixed-dose triple-drug bronchodilator comprising indacaterol, glycopyrronium, and mometasone for asthma management. DIFIZMA, available as a dry powder inhalation, stands out as the sole fixed-dose combination approved by the Drug Controller General of India (DCGI) for inadequately controlled asthma treatment. This innovative formulation demonstrates efficacy in improving lung function, enhancing symptom control, and reducing exacerbations in asthma patients. By offering such advanced solutions, companies such as Lupin aim to address unmet medical needs and contribute to the continued growth and advancement of the bronchodilator market.
In February 2023, AstraZeneca plc, a prominent pharmaceutical and biotechnology company headquartered in the UK, completed the acquisition of CinCor Pharma Inc. for $1.8 billion. This strategic move was driven by the shared goal of developing innovative treatments for uncontrolled hypertension and chronic kidney disease. Additionally, the acquisition is anticipated to bolster AstraZeneca's respiratory portfolio, which encompasses various bronchodilator products. CinCor Pharma, a US-based clinical-stage biopharmaceutical company specializing in the development of bronchodilator-related products, adds valuable expertise to AstraZeneca's endeavors in this therapeutic area.
Major companies operating in the bronchodilators market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Thermo Fisher Scientific, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline plc, Siemens Healthcare GmbH, Merck & Co. Inc., AstraZeneca plc, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Quest Diagnostics Incorporated., Boehringer Ingelheim International GmbH, Aurobindo Pharma Limited, Bio-Rad Laboratories Inc., Cipla Limited, Hikma Pharmaceutical plc, Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Vectura Group Limited, Foundation Medicine Inc., Sun Pharmaceutical Industries Ltd., Amgen Inc., Kissei Pharmaceutical Co.Ltd., Mitsubishi Tanabe Pharma, Theron Pharmaceuticals, Viatris Inc.
North America was the largest region in the bronchodilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bronchodilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bronchodilators market consists of sales of albuterol (proair, ventolin, proventil), formoterol (foradil, perforomist), salmeterol (serevent), tiotropium (spiriva) and ipratropium (atrovent). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bronchodilators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bronchodilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bronchodilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bronchodilators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Beta-Adrenergic Bronchodilators; Anticholinergic Bronchodilators; Xanthine Derivatives; Other Types
- 2) By Route of Administration: Oral; Nasal (Inhalation); Injectable
- 3) By Indication: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Allergic Reactions; Breathing Problem; Other Indications
- 4) By End-User: Hospitals; Specialty Clinics; Other End Users
- Subsegments:
- 1) By Beta-Adrenergic Bronchodilators: Short-Acting Beta Agonists (SABAs); Long-Acting Beta Agonists (LABAs)
- 2) By Anticholinergic Bronchodilators: Short-Acting Anticholinergics; Long-Acting Anticholinergics
- 3) By Xanthine Derivatives: Theophylline; Aminophylline
- 4) By Other Types: Leukotriene Receptor Antagonists; Combination Therapies
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Novartis AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bronchodilators Market Characteristics
3. Bronchodilators Market Trends And Strategies
4. Bronchodilators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Bronchodilators Growth Analysis And Strategic Analysis Framework
- 5.1. Global Bronchodilators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Bronchodilators Market Growth Rate Analysis
- 5.4. Global Bronchodilators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Bronchodilators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Bronchodilators Total Addressable Market (TAM)
6. Bronchodilators Market Segmentation
- 6.1. Global Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Beta-Adrenergic Bronchodilators
- Anticholinergic Bronchodilators
- Xanthine Derivatives
- Other Types
- 6.2. Global Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Nasal (Inhalation)
- Injectable
- 6.3. Global Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Allergic Reactions
- Breathing Problem
- Other Indications
- 6.4. Global Bronchodilators Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Specialty Clinics
- Other End Users
- 6.5. Global Bronchodilators Market, Sub-Segmentation Of Beta-Adrenergic Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Short-Acting Beta Agonists (SABAs)
- Long-Acting Beta Agonists (LABAs)
- 6.6. Global Bronchodilators Market, Sub-Segmentation Of Anticholinergic Bronchodilator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Short-Acting Anticholinergics
- Long-Acting Anticholinergics
- 6.7. Global Bronchodilators Market, Sub-Segmentation Of Xanthine Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Theophylline
- Aminophylline
- 6.8. Global Bronchodilators Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Leukotriene Receptor Antagonists
- Combination Therapies
7. Bronchodilators Market Regional And Country Analysis
- 7.1. Global Bronchodilators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Bronchodilators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bronchodilators Market
- 8.1. Asia-Pacific Bronchodilators Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bronchodilators Market
- 9.1. China Bronchodilators Market Overview
- 9.2. China Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bronchodilators Market
- 10.1. India Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bronchodilators Market
- 11.1. Japan Bronchodilators Market Overview
- 11.2. Japan Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bronchodilators Market
- 12.1. Australia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bronchodilators Market
- 13.1. Indonesia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bronchodilators Market
- 14.1. South Korea Bronchodilators Market Overview
- 14.2. South Korea Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bronchodilators Market
- 15.1. Western Europe Bronchodilators Market Overview
- 15.2. Western Europe Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bronchodilators Market
- 16.1. UK Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bronchodilators Market
- 17.1. Germany Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bronchodilators Market
- 18.1. France Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bronchodilators Market
- 19.1. Italy Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bronchodilators Market
- 20.1. Spain Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bronchodilators Market
- 21.1. Eastern Europe Bronchodilators Market Overview
- 21.2. Eastern Europe Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bronchodilators Market
- 22.1. Russia Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bronchodilators Market
- 23.1. North America Bronchodilators Market Overview
- 23.2. North America Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bronchodilators Market
- 24.1. USA Bronchodilators Market Overview
- 24.2. USA Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bronchodilators Market
- 25.1. Canada Bronchodilators Market Overview
- 25.2. Canada Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bronchodilators Market
- 26.1. South America Bronchodilators Market Overview
- 26.2. South America Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bronchodilators Market
- 27.1. Brazil Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bronchodilators Market
- 28.1. Middle East Bronchodilators Market Overview
- 28.2. Middle East Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bronchodilators Market
- 29.1. Africa Bronchodilators Market Overview
- 29.2. Africa Bronchodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Bronchodilators Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Bronchodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bronchodilators Market Competitive Landscape And Company Profiles
- 30.1. Bronchodilators Market Competitive Landscape
- 30.2. Bronchodilators Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Bronchodilators Market Other Major And Innovative Companies
- 31.1. Thermo Fisher Scientific
- 31.2. Abbott Laboratories
- 31.3. Sanofi S.A.
- 31.4. GlaxoSmithKline plc
- 31.5. Siemens Healthcare GmbH
- 31.6. Merck & Co. Inc.
- 31.7. AstraZeneca plc
- 31.8. Teva Pharmaceuticals Industries Ltd.
- 31.9. Mylan N.V.
- 31.10. Quest Diagnostics Incorporated.
- 31.11. Boehringer Ingelheim International GmbH
- 31.12. Aurobindo Pharma Limited
- 31.13. Bio-Rad Laboratories Inc.
- 31.14. Cipla Limited
- 31.15. Hikma Pharmaceutical plc
32. Global Bronchodilators Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Bronchodilators Market
34. Recent Developments In The Bronchodilators Market
35. Bronchodilators Market High Potential Countries, Segments and Strategies
- 35.1 Bronchodilators Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Bronchodilators Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Bronchodilators Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
